Gestora
G.I.I.C. FINECO, S.A., S.G.I.I.C.
Ver el universo de gestoras de la CNMV →
Ficha de fondo
FINECO INVESTMENT OFFICE, FI
Categoria
—
Ultimo periodo
2S 2025
Posiciones
136
Cartera notificada con cierre 2025-12-31. Fuente: informe periodico en la CNMV. Ver informe original (PDF)
Cartera completa
Todas las posiciones del ultimo informe periodico, de mayor a menor peso. Los agregados ("resto de renta variable...") son cestas de posiciones pequenas que el propio informe no desglosa linea a linea.
136
Empresa
Tipo
Pais
Peso
Precio
Movimientos del periodo
2S 2025 frente a 1S 2025 (estimada)
Nuevas: 26
Salidas: 24
Incrementos: 2
Recortes: 1
+ Acciones|DOLLAR GENERAL CORPORATION
Entra en la cartera con un 0.15% de peso.
Ver ficha de la empresa →+ Acciones|SINGAPORE TELECOMMUNICATIONS
Entra en la cartera con un 0.10% de peso.
Ver ficha de la empresa →+ Acciones|DOLLAR GENERAL CORPORATION
Entra en la cartera con un 0.10% de peso.
Ver ficha de la empresa →+ Acciones|ESTEE LAUDER COMPANIES INC
Entra en la cartera con un 0.09% de peso.
Ver ficha de la empresa →+ Acciones|TEVA PHARMACEUTICALS NE
Entra en la cartera con un 0.09% de peso.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Ver ficha de la empresa →+ Acciones|ALIBABA GROUP HOLDING
Entra en la cartera con un 0.09% de peso.
Ver ficha de la empresa →+ Acciones|THE WALT DISNEY COMPANY
Entra en la cartera con un 0.07% de peso.
Ver ficha de la empresa →+ Acciones|AGNICO EAGLE MINES LTD
Entra en la cartera con un 0.07% de peso.
Ver ficha de la empresa →+ Acciones|EATON CAPITAL UNLIMITED
Entra en la cartera con un 0.06% de peso.
Ver ficha de la empresa →− U. S. TREASURY
Sale de la cartera; tenia un 2.34% de peso.
− ESTADO ALEMAN
Sale de la cartera; tenia un 1.58% de peso.
− UNITED MEXICAN STATE
Sale de la cartera; tenia un 0.79% de peso.
− Acciones|AIA GROUP
Sale de la cartera; tenia un 0.18% de peso.
− Acciones|TEXAS INSTRUMENTS INC
Sale de la cartera; tenia un 0.18% de peso.
− Acciones|ARM HOLDINGS PLC
Sale de la cartera; tenia un 0.17% de peso.
− Acciones|HEINEKEN NV
Sale de la cartera; tenia un 0.14% de peso.
Heineken N.V. brews and sells beer and cider in Europe, the Americas, Africa, the Middle East, and the Asia Pacific. The company also provides soft drinks. It sells its products under the Heineken, Heineken 0.0, Heineken Silver, Amstel, Moretti, Tiger, Desperados, Edelweiss, Lagunitas, Orchard Thieves, Windhoek, Dos Equis, Red Stripe, Kingfisher, Bintang, Gosser, Affligem, Mort Subite, Strongbow, Stassen, Bulmers, Old Mout, Savanna, Turbo King, Tecate, Lagunitas Hoppy Refresher, Bia Viet, Tiger Crystal, Birra Moretti, Harar, Cruzcampo, Bernini, Legend Stout, Beavertown, Stëlz, Texels, Ladrón, Bandida, Stibitzer, El Aguila, and Murphy's brands. In addition, the company engages in rental of pubs and bars; wholesale activities; and pub management and technical services. The company offers its products to retailers, wholesalers and distributors, bars, restaurants, clubs, cafes, and hotels. Heineken N.V. was incorporated in 1864 and is headquartered in Amsterdam, the Netherlands. Heineken N.V. is a subsidiary of Heineken Holding N.V.
Ver ficha de la empresa →− Acciones|FORTINET INC
Sale de la cartera; tenia un 0.14% de peso.
− Acciones|PNC FINANCIAL SERVICES
Sale de la cartera; tenia un 0.13% de peso.
− Acciones|VERISIGN INC
Sale de la cartera; tenia un 0.12% de peso.
− Acciones|KEYENCE CORP
Sale de la cartera; tenia un 0.12% de peso.
− Acciones|COMPAGNIE FIN ET INDUS
Sale de la cartera; tenia un 0.11% de peso.
Compagnie de Saint-Gobain S.A., together with its subsidiaries, designs, manufactures, and distributes materials and solutions for the construction and industrial markets worldwide. It operates in five segments: High Performance Solutions; Northern Europe; Southern Europe Middle East (ME) Americas; and Asia-Pacific. The company offers plaster-based products and systems for the construction and renovation markets under the Placo, Rigips, and Gyproc brands; insulation solutions for a range of applications, such as heating and air conditioning systems, insulation of pipes in industrial installations, engine and interior compartments of vehicles, household appliances, and photovoltaic panels under the Isover, CertainTeed, and Izocam brands; and mortars and construction chemicals under the Weber, Chryso, and GCP brands. It also provides ceilings under the Ecophon, CertainTeed, Eurocoustic, Gyptone, and Vinh Tuong brands; glazing solutions for buildings and mobility, including flat glass under the Saint-Gobain Glass, GlassSolutions, Vetrotech, and SageGlass brands; ductile cast iron pipe systems, covers, and gratings under the PAM brand; glass fiber materials and technical textiles; and abrasives, adhesives, sealants, adhesive tapes, foams, and films. In addition, the company offers ceramics and polymers; and exterior products comprising asphalt and composite shingles, solar roofing solutions, roll roofing systems, accessories, polymer shakes and shingles, and insulation cladding solutions under the CertainTeed brands. Further, it distributes heavy building materials; plumbing, heating, ventilation, and sanitaryware products; construction products; office partitions; timber and byproducts; home improvement products and services; bathrooms and kitchens; steel; and site equipment, PPEs, and tools. Compagnie de Saint-Gobain S.A. was founded in 1665 and is headquartered in Courbevoie, France.
Ver ficha de la empresa →− Acciones|GARTNER INC
Sale de la cartera; tenia un 0.11% de peso.
− Acciones|INTL BUSINESS MACHINES CORP
Sale de la cartera; tenia un 0.11% de peso.
− Acciones|WALLMART
Sale de la cartera; tenia un 0.10% de peso.
− Acciones|UNILEVER NV-CVA
Sale de la cartera; tenia un 0.10% de peso.
− Acciones|GLAXOSMITHKLINE
Sale de la cartera; tenia un 0.10% de peso.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
Ver ficha de la empresa →− Acciones|CARRIER GLOBAL CORP
Sale de la cartera; tenia un 0.08% de peso.
− Acciones|COSTCO WHOLESALE CORP
Sale de la cartera; tenia un 0.07% de peso.
− Acciones|SMC CORP
Sale de la cartera; tenia un 0.07% de peso.
− Acciones|FAIR ISAAC CORP
Sale de la cartera; tenia un 0.07% de peso.
− Acciones|NUTRIEN LTD
Sale de la cartera; tenia un 0.05% de peso.
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The Nitrogen segment owns and operates ammonia production facilities that offers ammonia, urea, ammonium nitrate (UAN), urea solutions, nitric acid, and ammonium nitrate, as well as environmentally smart nitrogen and ammonium sulfate. The Phosphate segment manufactures and sells solid and liquid phosphate fertilizers, phosphate feed, and purified phosphoric acid, which is used in feed and industrial products. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Ver ficha de la empresa →− Acciones|MEITUAN CLASS B
Sale de la cartera; tenia un 0.05% de peso.
− Acciones|KLA CORP
Sale de la cartera; tenia un 0.05% de peso.
Renta fija
Exposición RF declarada
2.4 M €
% de la cartera
2.2%
Posiciones
3
Emisores
2
Soberano: 1.6 M €
Corporativo: 736,030 €
Escalera de vencimientos
Vencimiento contractual observado de cada posición, sin repos. Vencido/≤3 meses incluye bonos que vencen en los primeros días tras el cierre del periodo.
Vencido o ≤3 meses · 31.3%5-10 años · 32.3%> 10 años · 36.4%
Vencimiento
Posiciones
Exposición
%
Vencido o ≤3 meses
1
736,030 €
31.3%
3-6 meses
0
0 €
0.0%
6-12 meses
0
0 €
0.0%
1-2 años
0
0 €
0.0%
2-5 años
0
0 €
0.0%
5-10 años
1
759,414 €
32.3%
> 10 años
1
855,596 €
36.4%
Desconocido
0
0 €
0.0%
Top emisores
Los 10 emisores con mayor exposición declarada en este fondo, sin repos.
Emisor
Tipo
Nº ISIN
Exposición
Próximo vencimiento
Bundesrepublik Deutschland
Soberano
2
1.6 M €
2033-02-15
UNITED MEXICAN STATE
Corporativo
1
736,030 €
2026-01-08
Top instrumentos
Los 10 instrumentos con mayor exposición declarada. Sin yield, TIR ni rating: no hay dato fiable para calcularlos.
ISIN
Cupón
Vencimiento
Exposición
DE0001102614 Bundesrepublik Deutschland
1.80%
2053-08-15
855,596 €
DE000BU2Z007 Bundesrepublik Deutschland
2.30%
2033-02-15
759,414 €
MXBIGO000X35 UNITED MEXICAN STATE
50.00%
2026-01-08
736,030 €
Divisas
Exposición RF por divisa del instrumento.
Divisa
Exposición
%
EUR
1.6 M €
68.7%
MXN
736,030 €
31.3%
Movimientos de renta fija del periodo
Compara la cartera RF actual con la del periodo anterior, por ISIN. Una salida coincidente con vencimiento no es una venta: el bono llegó a su fecha contractual.
Nuevas posiciones: 1
Salidas por vencimiento: 2
Salidas no explicadas por vencimiento: 1
+ UNITED MEXICAN STATE
Entra en la cartera con un 0.70% de peso.
− ESTADO ALEMAN
Sale de la cartera; tenía un 1.58% de peso.
◦ U. S. TREASURY
Sale de la cartera; tenía un 2.34% de peso.
◦ UNITED MEXICAN STATE
Sale de la cartera; tenía un 0.79% de peso.
Aviso
Esto no es asesoramiento financiero. La cartera procede del informe periodico que el fondo presenta en la CNMV y llega con retraso respecto al cierre real del periodo: es una foto del final de cada semestre, no la cartera en tiempo real.